Portage Biotech (PRTG) News Today $4.50 -0.07 (-1.53%) (As of 01:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Portage Biotech's Market Cap Drops To US$4.3m Leaving Insiders With LossesNovember 17, 2024 | finance.yahoo.comUnited States shares lower at close of trade; Dow Jones Industrial Average down 0.25%September 19, 2024 | msn.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.59%August 30, 2024 | msn.comShort Interest in Portage Biotech Inc. (NASDAQ:PRTG) Decreases By 88.1%Portage Biotech Inc. (NASDAQ:PRTG - Get Free Report) saw a significant drop in short interest in the month of August. As of August 15th, there was short interest totalling 7,200 shares, a drop of 88.1% from the July 31st total of 60,600 shares. Currently, 0.1% of the company's shares are short sold. Based on an average daily trading volume, of 881,800 shares, the days-to-cover ratio is currently 0.0 days.August 27, 2024 | marketbeat.comPortage Biotech (NASDAQ:PRTG) Stock, Short Interest ReportAugust 25, 2024 | benzinga.comPortage Biotech Inc.August 25, 2024 | wsj.comPortage Biotech (NASDAQ:PRTG) Stock Quotes, Forecast and News SummaryAugust 24, 2024 | benzinga.comPRTG Stock Earnings: Portage Biotech Reported Results for Q4 2024August 15, 2024 | investorplace.comPortage Biotech Inc.: Portage Biotech Announces 1-for-20 Reverse Stock SplitAugust 14, 2024 | finanznachrichten.dePortage Biotech Announces 1-for-20 Reverse Stock SplitAugust 13, 2024 | finance.yahoo.comPortage Biotech Inc. (PRTG)July 27, 2024 | finance.yahoo.comPortage Biotech Inc (PRTG)May 16, 2024 | uk.investing.comPortage Biotech halts trial enrollment, seeks strategic optionsApril 14, 2024 | investing.comPortage Down on Announcing AlternativesApril 12, 2024 | msn.comPortage Biotech Announces Plans to Expand its Evaluation of Strategic AlternativesApril 12, 2024 | globenewswire.comPortage Biotech Completes Monetization of Intensity Therapeutics (INTS) sharesMarch 26, 2024 | globenewswire.comPRTG: Extending the RunwayMarch 11, 2024 | finance.yahoo.comPortage Biotech Inc PRTGMarch 3, 2024 | morningstar.comPortage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business UpdateFebruary 28, 2024 | globenewswire.comH.C. Wainwright downgrades Portage Biotech on financing overhangJanuary 8, 2024 | realmoney.thestreet.comPortage Biotech just downgraded at H.C. Wainwright, here's whyJanuary 8, 2024 | realmoney.thestreet.comPRTG: Bridging I-O: Working in Harmony with CheckpointsJanuary 8, 2024 | finance.yahoo.comPortage Biotech Shares Fall 6% on Job Reductions, Paused Drug Development ProgramJanuary 4, 2024 | marketwatch.comPortage Biotech To Pause INKT Clinical Development; To Evaluate Potential Strategic OptionsJanuary 4, 2024 | markets.businessinsider.comPortage Biotech to halt iNKT drug program, cut workforceJanuary 4, 2024 | msn.comPortage Biotech Reports Business and Strategic UpdateJanuary 4, 2024 | finance.yahoo.comPortage Biotech GAAP EPS of -$0.29November 28, 2023 | msn.comPortage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business UpdateNovember 28, 2023 | finance.yahoo.comPortage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer's (SITC) 38th Annual MeetingNovember 6, 2023 | benzinga.comPortage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual MeetingNovember 6, 2023 | finance.yahoo.comPortage Biotech files to sell 9.63M shares for holdersOctober 31, 2023 | msn.comPortage Biotech Announces $6.0 Million Registered Direct OfferingSeptember 29, 2023 | finance.yahoo.comPortage Biotech to Participate in Panel Discussion at the Cantor Global Healthcare ConferenceSeptember 20, 2023 | finance.yahoo.comAnalyst Expectations for Portage Biotech's FutureSeptember 7, 2023 | markets.businessinsider.comPortage Biotech in Keytruda Collaboration With MerckSeptember 5, 2023 | marketwatch.comPortage Biotech Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagonists in Combination with KEYTRUDA® (Pembrolizumab) in Solid TumorsSeptember 5, 2023 | finance.yahoo.comCantor Fitzgerald Reiterates Portage Biotech (PRTG) Overweight RecommendationSeptember 1, 2023 | msn.comPortage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business UpdateAugust 30, 2023 | finance.yahoo.comHC Wainwright & Co. Maintains Portage Biotech (PRTG) Buy RecommendationAugust 2, 2023 | msn.comPortage Biotech Inc (PRTG) Receives a Buy from H.C. WainwrightAugust 2, 2023 | markets.businessinsider.comUniversity Hospitals Portage Medical CenterAugust 2, 2023 | health.usnews.comCantor Fitzgerald Maintains Portage Biotech (PRTG) Overweight RecommendationAugust 1, 2023 | msn.comPortage Biotech Reports Fiscal Year-Ended March 31, 2023 Financial Results and Business UpdateJuly 31, 2023 | finance.yahoo.comPortage Biotech Announces First Patient Dosed in Phase 1a Trial of PORT-6 in Select Solid TumorsJune 26, 2023 | finance.yahoo.comWhy Portage Biotech Stock Is Up TodayJune 5, 2023 | benzinga.comPortage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 American Society for Clinical Oncology (ASCO) Annual MeetingJune 5, 2023 | finance.yahoo.comTrading was temporarily halted for "PRTG" at 09:06 AM with a stated reason of "LULD pause."June 5, 2023 | marketbeat.comPortage Biotech to Participate in Panel Discussion During the 2023 BIO International ConferenceJune 1, 2023 | finance.yahoo.comPortage Central High SchoolApril 29, 2023 | usnews.comPortage Biotech Announces Upcoming PORT-2 Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingApril 26, 2023 | finance.yahoo.com Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. PRTG Media Mentions By Week PRTG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTG News Sentiment▼0.000.47▲Average Medical News Sentiment PRTG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTG Articles This Week▼10▲PRTG Articles Average Week Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Finch Therapeutics Group News ProPhase Labs News Bullfrog AI News NanoViricides News Enlivex Therapeutics News Cognition Therapeutics News Flora Growth News Marinus Pharmaceuticals News Cara Therapeutics News Tenax Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRTG) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
